Clinical Trials

There
are 2 clinical trials
for neuroendocrine neoplasm, of which 2
are
open and 0
are
completed or closed.
Of the
trials that contain
neuroendocrine neoplasm as an inclusion criterion, 2 are phase 2 (2 open).

Cabozantinib, nivolumab, and ipilimumab
are the most common
interventions in
neuroendocrine neoplasm clinical trials.

Drugs Being Investigated in Neuroendocrine Neoplasm Trials by Recruiting Status

References

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.